Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to -$2.0 billion.

  • Fresenius Medical Care AG's Enterprise Value fell 3611.1% to -$2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 billion, marking a year-over-year decrease of 3611.1%. This contributed to the annual value of -$1.7 billion for FY2024, which is 2320.6% down from last year.
  • Fresenius Medical Care AG's Enterprise Value amounted to -$2.0 billion in Q3 2025, which was down 3611.1% from -$1.9 billion recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Enterprise Value peaked at -$1.2 billion during Q3 2021, and registered a low of -$2.0 billion during Q3 2025.
  • For the 5-year period, Fresenius Medical Care AG's Enterprise Value averaged around -$1.5 billion, with its median value being -$1.5 billion (2024).
  • In the last 5 years, Fresenius Medical Care AG's Enterprise Value tumbled by 4457.96% in 2021 and then surged by 1839.44% in 2023.
  • Fresenius Medical Care AG's Enterprise Value (Quarter) stood at -$1.7 billion in 2021, then rose by 8.62% to -$1.6 billion in 2022, then increased by 9.84% to -$1.4 billion in 2023, then fell by 23.21% to -$1.7 billion in 2024, then dropped by 18.1% to -$2.0 billion in 2025.
  • Its Enterprise Value stands at -$2.0 billion for Q3 2025, versus -$1.9 billion for Q2 2025 and -$1.7 billion for Q1 2025.